Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region.
Josiane M DiasIara V V SantanaVinicius Duval da SilvaAndré L CarvalhoLidia Maria Rebolho Batista ArantesPublished in: International journal of molecular sciences (2022)
This study corresponds to one of the largest cohorts of NPC in a non-endemic region. Phase III studies with checkpoint inhibitors are ongoing and may provide more data about the role of PD-L1 expression in this disease.
Keyphrases
- epstein barr virus
- phase iii
- diffuse large b cell lymphoma
- end stage renal disease
- ejection fraction
- clinical trial
- open label
- newly diagnosed
- chronic kidney disease
- prognostic factors
- dna damage
- peritoneal dialysis
- electronic health record
- big data
- machine learning
- oxidative stress
- artificial intelligence
- case control